A 64-year-old man with type 2 diabetes mellitus and stage 4 chronic kidney disease is evaluated for continued glycemic management. He is followed closely by the nephrology service in preparation for impending hemodialysis, with initiation of erythropoietin therapy within the last 3 months. His average fasting and preprandial blood glucose values are in the 145 to 190 mg/dL (8.0-10.5 mmol/L) range. He does not have hypoglycemia. His insulin regimen consists of insulin detemir at bedtime and insulin glulisine before meals. His most recent hemoglobin A1c value has decreased from 7.5% to 6.2%.

Which of the following is the most appropriate management for this patient's diabetes?